Enrolling by invitationNCT05509855

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Wugen, Inc.
Principal Investigator
Cherry Thomas, MD
Wugen, Inc.
Intervention
Genetic: WU-CART-007(genetic)
Enrollment
44 enrolled
Eligibility
12 years · All sexes
Timeline
20222037

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05509855 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials